Quest Diagnostics Incorporated Stock Beta

DGX Stock

USD 170.16 1.34 0.79%

Quest Diagnostics Incorporated fundamentals help investors to digest information that contributes to Quest Diagnostics' financial success or failures. It also enables traders to predict the movement of Quest Stock. The fundamental analysis module provides a way to measure Quest Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Quest Diagnostics stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Quest Diagnostics Incorporated Company Beta Analysis

Quest Diagnostics' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

Covariance

Variance

More About Beta | All Equity Analysis

Current Quest Diagnostics Beta

0.92

Most of Quest Diagnostics' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quest Diagnostics Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Quest Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for Quest Diagnostics is extremely important. It helps to project a fair market value of Quest Stock properly, considering its historical fundamentals such as Beta. Since Quest Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Quest Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Quest Diagnostics' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.66	0.86	0.29	0.94	0.99	0.87	0.39	0.79	0.87	0.96	0.66	0.97	-0.77	0.51	0.35	0.83	0.28	0.18	-0.14	0.31	0.64	0.42	-0.05
Total Stockholder Equity	0.99		0.61	0.87	0.23	0.96	0.95	0.88	0.3	0.76	0.82	0.92	0.65	0.94	-0.8	0.5	0.43	0.82	0.31	0.26	-0.24	0.33	0.6	0.48	-0.01
Net Debt	0.66	0.61		0.84	0.79	0.56	0.7	0.48	0.68	0.59	0.73	0.74	0.82	0.76	-0.61	0.51	0.0	0.73	0.38	-0.14	0.3	0.11	0.75	-0.03	-0.72
Retained Earnings	0.86	0.87	0.84		0.52	0.82	0.82	0.74	0.48	0.67	0.74	0.82	0.79	0.87	-0.89	0.52	0.37	0.82	0.53	0.24	-0.04	0.33	0.69	0.3	-0.41
Accounts Payable	0.29	0.23	0.79	0.52		0.25	0.33	0.25	0.55	0.1	0.51	0.38	0.74	0.35	-0.18	0.47	0.11	0.58	0.41	-0.29	0.41	0.13	0.81	-0.04	-0.94
Net Receivables	0.94	0.96	0.56	0.82	0.25		0.89	0.93	0.3	0.68	0.75	0.83	0.66	0.87	-0.7	0.53	0.5	0.78	0.27	0.17	-0.31	0.46	0.61	0.65	-0.03
Total Liab	0.99	0.95	0.7	0.82	0.33	0.89		0.83	0.47	0.8	0.9	0.97	0.65	0.97	-0.72	0.5	0.27	0.83	0.25	0.09	-0.04	0.27	0.66	0.36	-0.08
Total Current Assets	0.87	0.88	0.48	0.74	0.25	0.93	0.83		0.38	0.54	0.64	0.74	0.62	0.74	-0.6	0.63	0.65	0.76	0.3	0.17	-0.16	0.7	0.68	0.77	-0.04
Short Term Debt	0.39	0.3	0.68	0.48	0.55	0.3	0.47	0.38		0.26	0.52	0.39	0.5	0.42	-0.35	0.3	0.0	0.45	0.39	-0.12	0.7	0.38	0.62	-0.03	-0.52
Common Stock	0.79	0.76	0.59	0.67	0.1	0.68	0.8	0.54	0.26		0.68	0.84	0.28	0.86	-0.72	0.28	-0.15	0.44	0.21	0.16	-0.09	0.04	0.21	0.08	0.02
Intangible Assets	0.87	0.82	0.73	0.74	0.51	0.75	0.9	0.64	0.52	0.68		0.91	0.63	0.89	-0.61	0.35	0.13	0.81	0.37	0.07	0.11	0.08	0.71	0.13	-0.26
Long Term Debt	0.96	0.92	0.74	0.82	0.38	0.83	0.97	0.74	0.39	0.84	0.91		0.63	0.98	-0.73	0.46	0.18	0.83	0.29	0.13	-0.07	0.15	0.63	0.24	-0.15
Property Plant Equipment	0.66	0.65	0.82	0.79	0.74	0.66	0.65	0.62	0.5	0.28	0.63	0.63		0.67	-0.46	0.66	0.38	0.84	0.19	-0.24	0.06	0.25	0.87	0.28	-0.62
Good Will	0.97	0.94	0.76	0.87	0.35	0.87	0.97	0.74	0.42	0.86	0.89	0.98	0.67		-0.79	0.45	0.16	0.79	0.26	0.1	-0.08	0.13	0.6	0.24	-0.15
Treasury Stock	-0.77	-0.8	-0.61	-0.89	-0.18	-0.7	-0.72	-0.6	-0.35	-0.72	-0.61	-0.73	-0.46	-0.79		-0.24	-0.3	-0.62	-0.6	-0.53	0.13	-0.25	-0.36	-0.2	0.1
Current Deferred Revenue	0.51	0.5	0.51	0.52	0.47	0.53	0.5	0.63	0.3	0.28	0.35	0.46	0.66	0.45	-0.24		0.43	0.54	0.14	-0.25	0.17	0.46	0.68	0.41	-0.39
Net Tangible Assets	0.35	0.43	0.0	0.37	0.11	0.5	0.27	0.65	0.0	-0.15	0.13	0.18	0.38	0.16	-0.3	0.43		0.51	0.36	0.39	-0.3	0.69	0.49	0.76	0.03
Long Term Debt Total	0.83	0.82	0.73	0.82	0.58	0.78	0.83	0.76	0.45	0.44	0.81	0.83	0.84	0.79	-0.62	0.54	0.51		0.39	0.15	-0.09	0.37	0.84	0.4	-0.37
Capital Surpluse	0.28	0.31	0.38	0.53	0.41	0.27	0.25	0.3	0.39	0.21	0.37	0.29	0.19	0.26	-0.6	0.14	0.36	0.39		0.65	0.22	0.41	0.37	0.1	-0.4
Long Term Investments	0.18	0.26	-0.14	0.24	-0.29	0.17	0.09	0.17	-0.12	0.16	0.07	0.13	-0.24	0.1	-0.53	-0.25	0.39	0.15	0.65		-0.3	0.27	-0.16	0.17	0.3
Short Long Term Debt	-0.14	-0.24	0.3	-0.04	0.41	-0.31	-0.04	-0.16	0.7	-0.09	0.11	-0.07	0.06	-0.08	0.13	0.17	-0.3	-0.09	0.22	-0.3		0.04	0.3	-0.45	-0.47
Cash And Equivalents	0.31	0.33	0.11	0.33	0.13	0.46	0.27	0.7	0.38	0.04	0.08	0.15	0.25	0.13	-0.25	0.46	0.69	0.37	0.41	0.27	0.04		0.4	0.76	-0.09
Net Invested Capital	0.64	0.6	0.75	0.69	0.81	0.61	0.66	0.68	0.62	0.21	0.71	0.63	0.87	0.6	-0.36	0.68	0.49	0.84	0.37	-0.16	0.3	0.4		0.34	-0.62
Net Working Capital	0.42	0.48	-0.03	0.3	-0.04	0.65	0.36	0.77	-0.03	0.08	0.13	0.24	0.28	0.24	-0.2	0.41	0.76	0.4	0.1	0.17	-0.45	0.76	0.34		0.18
Capital Stock	-0.05	-0.01	-0.72	-0.41	-0.94	-0.03	-0.08	-0.04	-0.52	0.02	-0.26	-0.15	-0.62	-0.15	0.1	-0.39	0.03	-0.37	-0.4	0.3	-0.47	-0.09	-0.62	0.18

Click cells to compare fundamentals

In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

Competition

Predict Quest Diagnostics

In accordance with the recently published financial statements, Quest Diagnostics Incorporated has a Beta of 0.919. This is 6.86% higher than that of the Health Care Providers & Services sector and 36.18% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.

Quest Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Quest Diagnostics' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Quest Diagnostics could also be used in its relative valuation, which is a method of valuing Quest Diagnostics by comparing valuation metrics of similar companies.

Quest Diagnostics is currently under evaluation in beta category among its peers.

Quest Diagnostics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Quest Diagnostics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Quest Diagnostics' managers, analysts, and investors.

Environmental

Governance

Social

Quest Diagnostics Institutional Holders

Institutional Holdings refers to the ownership stake in Quest Diagnostics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Quest Diagnostics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Quest Diagnostics' value.

		Shares
Morgan Stanley - Brokerage Accounts	2024-12-31	1.6 M
American Century Companies Inc	2024-12-31	1.5 M
Wells Fargo & Co	2024-12-31	1.4 M
Amvescap Plc.	2024-12-31	1.4 M
Fiduciary Management, Inc. Of Milwaukee	2024-12-31	1.3 M
Norges Bank	2024-12-31	1.3 M
Northern Trust Corp	2024-12-31	1.2 M
Fmr Inc	2024-12-31	1.1 M
Alliancebernstein L.p.	2024-12-31	1.1 M
Vanguard Group Inc	2024-12-31	14 M
Blackrock Inc	2024-12-31	10.1 M

Quest Diagnostics returns are very sensitive to returns on the market. As the market goes up or down, Quest Diagnostics is expected to follow.

Quest Fundamentals

	Return On Equity	0.14
	Return On Asset	0.0584
	Profit Margin	0.09 %
	Operating Margin	0.14 %
	Current Valuation	25.42 B
	Shares Outstanding	110.98 M
	Shares Owned By Insiders	0.44 %
	Shares Owned By Institutions	93.73 %
	Number Of Shares Shorted	2.57 M
	Price To Earning	14.57 X
	Price To Book	2.79 X
	Price To Sales	1.91 X
	Revenue	9.87 B
	Gross Profit	3.27 B
	EBITDA	1.91 B
	Net Income	921 M
	Cash And Equivalents	315 M
	Cash Per Share	6.15 X
	Total Debt	6.92 B
	Debt To Equity	0.73 %
	Current Ratio	1.46 X
	Book Value Per Share	61.06 X
	Cash Flow From Operations	1.33 B
	Short Ratio	2.12 X
	Earnings Per Share	7.69 X
	Price To Earnings To Growth	1.39 X
	Target Price	176.97
	Number Of Employees	45 K
	Beta	0.92
	Market Capitalization	18.88 B
	Total Asset	16.15 B
	Retained Earnings	9.36 B
	Working Capital	223 M
	Current Asset	1.5 B
	Current Liabilities	1.17 B
	Annual Yield	0.02 %
	Five Year Return	1.89 %
	Net Asset	16.15 B
	Last Dividend Paid	3.0

About Quest Diagnostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Quest Diagnostics Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quest Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quest Diagnostics Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
CRM	Salesforce
CRM	Salesforce

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC